Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Asia.
Press releases published on June 2, 2025
Comprehensive Insights of the Global Inspection Management Software Market: Key Drivers, and Forecast for 2025-2034
EIN Presswire
·
June 2, 2025
The Business Research Company’s Inspection Management Software Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /EINPresswire.com/ -- What Is The Projected Market Size Of The …
Zamorins Solutions broadens its global footprint with cutting-edge IT services
EIN Presswire
·
June 2, 2025
Zamorins Solutions announced its global growth, providing innovative IT services such as AI, web and app development, and digital transformation. DES MOINES, IA, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- Zamorins Solutions, an innovative …
Live from ASCO 2025 | Ascentage Pharma Releases Promising Clinical Data on Alrizomadlin Monotherapy and Combinations in Solid Tumors
GlobeNewswire
·
June 2, 2025
ROCKVILLE, Md. and SUZHOU, China, June 02, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest clinical …
Live from ASCO 2025 | Ascentage Pharma Presents Clinical Data on Bcl-2 Inhibitor Lisaftoclax in Venetoclax-Refractory Patients in Oral Report
GlobeNewswire
·
June 2, 2025
ROCKVILLE, Md. and SUZHOU, China, June 02, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest data from …
Nxera Pharma to Receive US$15 Million from Neurocrine Biosciences Following Dosing of First Patient in Phase 3 Trial of NBI-1117568
GlobeNewswire
·
June 2, 2025
Tokyo, Japan and Cambridge, UK, 3 June 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that its partner, Neurocrine Biosciences (“Neurocrine”) has dosed the first patient in its Phase 3 registrational program of NBI- …
Semilux Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 20-F
GlobeNewswire
·
June 2, 2025
Taipei, Taiwan, June 02, 2025 (GLOBE NEWSWIRE) -- Semilux International Ltd. (NASDAQ:SELX) (“SELX” or the “Company”) announced that it received a delinquency notification letter on May 27, 2025 (the “Deficiency Letter”) from the Listing Qualifications …
Eupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders
GlobeNewswire
·
June 2, 2025
VICTORIA, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology designed to …
𝗧𝗲𝗰𝗵𝗥𝗮𝗻𝗸 𝗔𝘂𝘀𝘁𝗿𝗮𝗹𝗶𝗮 𝗟𝗮𝘂𝗻𝗰𝗵𝗲𝗱 𝗜𝗻𝘀𝘁𝗮𝗻𝘁 𝗪𝗲𝗯𝘀𝗶𝘁𝗲 𝗗𝗲𝘀𝗶𝗴𝗻 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀; 𝗘𝗺𝗽𝗼𝘄𝗲𝗿𝗶𝗻𝗴 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀𝗲𝘀 𝘁𝗼 𝗟𝗮𝘂𝗻𝗰𝗵 𝗢𝗻𝗹𝗶𝗻𝗲 𝗶𝗻 𝟳 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗗𝗮𝘆𝘀
EIN Presswire
·
June 2, 2025
𝗦𝗺𝗮𝗹𝗹 𝗯𝘂𝘀𝗶𝗻𝗲𝘀𝘀𝗲𝘀 𝗰𝗮𝗻 𝗻𝗼𝘄 𝗹𝗮𝘂𝗻𝗰𝗵 𝗺𝗼𝗯𝗶𝗹𝗲-𝗳𝗿𝗶𝗲𝗻𝗱𝗹𝘆, 𝗦𝗘𝗢-𝗼𝗽𝘁𝗶𝗺𝗶𝘇𝗲𝗱 𝘄𝗲𝗯𝘀𝗶𝘁𝗲𝘀 𝗶𝗻 𝗷𝘂𝘀𝘁 𝟳 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗗𝗮𝘆𝘀 𝗼𝗿 𝗿𝗲𝗰𝗲𝗶𝘃𝗲 𝗮 𝗳𝘂𝗹𝗹 𝗿𝗲𝗳𝘂𝗻𝗱 MELBOURNE, VICTORIA, AUSTRALIA, June 2, 2025 /EINPresswire.com/ -- 𝗧𝗲𝗰𝗵𝗥𝗮𝗻𝗸 𝗔𝘂𝘀𝘁𝗿𝗮𝗹𝗶𝗮, a Melbourne-based full-service 𝗱𝗶𝗴𝗶𝘁𝗮𝗹 …
FansHash Empowers Global Investors with Daily Passive Income via Cloud Mining
GlobeNewswire
·
June 2, 2025
London, UK, June 02, 2025 (GLOBE NEWSWIRE) -- As Bitcoin approaches its all-time high, Fanshash’s user-friendly, maintenance-free cloud mining platform has attracted a surge of miners, gaining significant momentum. Amid the latest crypto market rally, …
Kura Oncology and Kyowa Kirin Report Positive Pivotal Ziftomenib Monotherapy Data at 2025 ASCO Annual Meeting
GlobeNewswire
·
June 2, 2025
– CR/CRh rate of 23% in pivotal Ph 2 cohort of R/R NPM1-m AML patients – – Consistent efficacy with comparable CR/CRh rates and clinically meaningful MRD-negative responses across pre-specified subgroups, regardless of prior HSCT, prior venetoclax, or FLT3 …
Lutra Introduces Makeyourmascot.com, an AI Mascot Generator for Small Businesses
EIN Presswire
·
June 2, 2025
Create a custom mascot in under a minute using just your Google Maps Store Information — powered by Lutra’s AI tool for small business branding. NEW YORK, NY, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- Lutra, a brand-tech company based in South …
MDB Capital Holdings Announces Transitions In Its Board of Directors
GlobeNewswire
·
June 2, 2025
Addison, TX, June 02, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading disruptive technology companies, today announced key leadership transitions within its Board …
ETP Group Presents AI-Powered, Cloud-Native Unified Commerce Solutions at NRF 2025 – Retail's Big Show APAC, Singapore
EIN Presswire
·
June 2, 2025
SINGAPORE, June 2, 2025 /EINPresswire.com/ -- The retail industry in Asia Pacific is at a critical crossroads—reshaped by digital disruption, shifting consumer expectations, and the rapid adoption of AI and real-time commerce. For CXOs navigating this …
Quest PharmaTech Provides Corporate Update
GlobeNewswire
·
June 2, 2025
EDMONTON, Alberta, June 02, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary …
SunnyMining Gains Institutional Interest as Cloud Mining Sees Accelerated Adoption
GlobeNewswire
·
June 2, 2025
Boston, Massachusetts, June 02, 2025 (GLOBE NEWSWIRE) -- SunnyMining's latest report shows that as the popularity of cryptocurrencies continues to rise, an increasing number of users from platforms like Coinbase and Kraken are turning to cloud mining. …
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 2, 2025
SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …
Harvard Bioscience Appoints John Duke to Board of Directors
GlobeNewswire
·
June 2, 2025
HOLLISTON, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the appointment of John Duke to its board of directors, effective June 2, 2025. Mr. Duke will also serve on the audit and nominating …
Cloud Mining in 2025: How VNBTC Is Reshaping Free Crypto Income Opportunities Globally
GlobeNewswire
·
June 2, 2025
London, UK, June 02, 2025 (GLOBE NEWSWIRE) -- As cloud mining becomes one of the fastest-growing passive income methods in the digital asset space, VNBTC, a free cloud mining platform, is rapidly gaining global recognition for making free cloud mining both …
Altai Announces Repositioning of Investment Portfolio to Maximize Liquidity
GlobeNewswire
·
June 2, 2025
TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Altai Resources Inc. (TSXV: ATI) (“Altai” or the “Company”) announced today that the Company has completed the repositioning of its Canadian investment portfolio (the “Investment Portfolio”) through the sale of …
Positive Updates on Select Development Assets Outside of Current 5-Year Outlook & Acquisition of Silver Stream on South Railroad Project
GlobeNewswire
·
June 2, 2025
MONTRÉAL, June 02, 2025 (GLOBE NEWSWIRE) -- OR Royalties Inc. (the “Company” or “OR Royalties” or “OR”) (OR: TSX …